Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.41 USD
Change Today -0.04 / -1.63%
Volume 544.3K
ATRS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul K. Wotton Ph.D.

Former Chief Executive Officer, President and Director, Antares Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 2 different organizations across 5 different industries.

See Board Relationships
54$4,303,795
As of Fiscal Year 2014

Background*

Dr. Paul K. Wotton, Ph.D. has been Chief Executive Officer and President of Ocata Therapeutics, Inc. (alternative name Advanced Cell Technology Inc.) since July 2014. Dr. Wotton has over 20 years of experience in the pharmaceutical industry with both large and specialty pharma companies. He served as the Chief Executive Officer of Antares Pharma Inc. since October 2008 until June 2014 and served as its President since July 2008 until June 2014. Dr. Wotton served as the ...

Read Full Background

Corporate Headquarters*

100 Princeton South
Ewing, New Jersey 08628

United States

Phone: 609-359-3020
Fax: --

Board Members Memberships*

Former Chief Executive Officer, President and Executive Director
2004-2014
Former Chief Executive Officer, President and Director
2008-N/A
Director
2014-Present
Chief Executive Officer, President, Director and Member of Pricing Committee
2015-Present
Director and Member of Corporate Governance & Nominating Committee

Education*

Bachelor's Degree
University Of London
MBA
Kingston Business School
PhD
Nottingham University

Other Affiliations*

Annual Compensation*

Salary$243,269
Bonus$71,156
Total Annual Compensation$314,425

Stock Options*

Restricted Stock Awards$1,965,000
All Other Compensation$44,370
Unexercisable Options300,000
Total Number of Options300,000

Total Compensation*

Total Annual Cash Compensation$358,795
Total Short Term Compensation$314,425
Other Long Term Compensation$2,009,370
Total Calculated Compensation$4,303,795
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRS:US $2.41 USD -0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$599.8K
Olav Hellebo Chief Executive Officer and Director
ReNeuron Group plc
--
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, Chief Financial Officer, General Counsel and Director
Neuralstem, Inc.
$651.2K
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
$362.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTARES PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.